Stock Report

Download full stock data and analysis for free Last Updated: 08-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Syndax Pharmaceuticals (SNDX) Peer Comparison

Stock Card factsheet share-fund-plan-icon

$20.56

up-down-arrow $-0.12 (-0.58%)

As on 04-Sep-2026 19:13EDT

Market cap

info icon

$1,836 Mln

Revenue (TTM)

info icon

$252 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

122.9

Div. Yield

info icon

0 %

Edit peer-selector-edit
Syndax Pharmaceuticals (SNDX) Medpace Holdings (MEDP) Ascendis Pharma A/S - ADR Exelixis (EXEL) Madrigal Pharmaceuticals (MDGL)
Market cap ($ Mln)
 1,836 16,504 17,747 14,622 12,501
Revenue ($ Mln)
 252 2,782 1,054 2,436 1,284
Net Profit ($ Mln)
 -220.77 491.50 755.85 860.62 -325.10
Net Margin (%)
 -87.60 17.67 71.69 35.33 -25.32
RoE (%)
 -553.79 110.09 -- 42.98 -57.72
Price to Earnings
 -- 34.72 20.93 18.56 --
Price-To-Book
 122.90 38.18 10.51 7.95 23.94

Income Statement ($ Mln)

Syndax Pharmaceuticals (SNDX) Medpace Holdings (MEDP) Ascendis Pharma A/S - ADR Exelixis (EXEL) Madrigal Pharmaceuticals (MDGL)
Operating Revenue arrow
252.00 2,782.29 1,054.37 2,435.92 1,283.94
Cost of Revenue arrow
6.37 1,982.07 103.47 85.67 109.42
Gross Profit arrow
165.38 760.62 588.53 2,236.43 902.26
Operating Expenses arrow
439.81 216.81 841.45 1,378.74 1,497.13
Operating Profit (EBIT) arrow
-194.17 583.40 109.45 971.51 -322.62
Other Income arrow
0.00 0.00 0.00 0.00 0.00
Profit before Tax arrow
-220.77 598.92 101.11 1,035.47 -325.10
Provision for Tax arrow
0.00 107.42 -654.74 174.84 0.00
Profit after Tax (Net Income) arrow
-220.77 491.50 755.85 860.62 -325.10
Minority Interest arrow
0.00 0.00 0.00 0.00 0.00
Consolidated Profit arrow
0.00 0.00 0.00 0.00 0.00

Liabilities ($ Mln)

Syndax Pharmaceuticals (SNDX) Medpace Holdings (MEDP) Ascendis Pharma A/S - ADR Exelixis (EXEL) Madrigal Pharmaceuticals (MDGL)
Shareholder's Funds arrow
15.10 433.86 1,435.90 1,843.76 523.72
Minority Interest arrow
0.00 0.00 0.00 0.00 0.00
Non-Current Liabilities arrow
588.88 187.89 384.48 288.55 346.72
Current Liabilities arrow
99.68 1,435.43 464.70 361.93 374.20
Total Liabilities arrow
529.71 1,975.47 1,302.02 2,844.42 1,259.59

Assets ($ Mln)

Syndax Pharmaceuticals (SNDX) Medpace Holdings (MEDP) Ascendis Pharma A/S - ADR Exelixis (EXEL) Madrigal Pharmaceuticals (MDGL)
Non-Current Assets arrow
29.12 1,006.90 895.24 1,243.41 45.47
Current Assets arrow
675.04 1,050.29 1,389.84 1,250.82 1,199.18
Total Assets arrow
529.71 1,975.47 1,302.02 2,844.42 1,259.59
Total Debt* arrow
589.38 120.10 449.89 165.93 347.75
Net Current Assets arrow
575.36 -385.14 925.52 888.90 824.98

Cashflow ($ Mln)

Syndax Pharmaceuticals (SNDX) Medpace Holdings (MEDP) Ascendis Pharma A/S - ADR Exelixis (EXEL) Madrigal Pharmaceuticals (MDGL)
Cash From Operating Activities arrow
-322.98 713.22 51.77 884.27 -189.55
Cash Flow from Investing Activities arrow
290.04 -31.14 -8.15 350.44 32.32
Cash from Financing Activities arrow
13.68 -860.39 34.89 -969.59 255.98
Net Cash Inflow / Outflow arrow
-- -- -- -- --

Ratios

Profitability Ratios

 Syndax Pharmaceuticals (SNDX) Medpace Holdings (MEDP) Ascendis Pharma A/S - ADR Exelixis (EXEL) Madrigal Pharmaceuticals (MDGL)
ROCE (%) arrow
-54.63 53.56 -30.01 32.82 -31.49
ROE (%) arrow
-553.79 110.09 163.18 42.98 -57.72
ROA (%) arrow
-29.19 15.64 31.68 29.32 -22.97
EBIT Margin (%) arrow
-39.11 21.13 5.73 31.04 -18.97
Net Margin (%) arrow
-87.60 17.67 71.69 35.33 -25.32
Cash Profit Margin (%) arrow
-0.01 0.00 0.00 0.00 0.00

Growth Ratios

 Syndax Pharmaceuticals (SNDX) Medpace Holdings (MEDP) Ascendis Pharma A/S - ADR Exelixis (EXEL) Madrigal Pharmaceuticals (MDGL)
Revenue Growth (%) arrow
222.34 24.67 114.85 9.23 149.04
EBIT Growth (%) arrow
70.78 18.70 136.39 -3.99 9.16
Net Profit Growth (%) arrow
34.10 17.50 378.76 42.89 -15.32
EPS Growth (%) arrow
35.13 26.84 353.27 50.42 -0.64
Book Value Growth (%) arrow
-90.69 164.02 816.12 -0.70 -42.66

Valuation Ratios

 Syndax Pharmaceuticals (SNDX) Medpace Holdings (MEDP) Ascendis Pharma A/S - ADR Exelixis (EXEL) Madrigal Pharmaceuticals (MDGL)
Price / Earnings arrow
-6.38 36.06 -59.76 15.79 -45.32
Price / Book Value arrow
28.16 35.44 -80.42 5.72 21.68
Dividend Yield (%) arrow
-- -- -- -- --
EV/EBITDA arrow
-6.97 28.08 -121.54 12.44 -47.02
Market Cap ($ Cr) arrow
-- -- -- -- --

Solvency Ratios

 Syndax Pharmaceuticals (SNDX) Medpace Holdings (MEDP) Ascendis Pharma A/S - ADR Exelixis (EXEL) Madrigal Pharmaceuticals (MDGL)
Debt to Equity arrow
38.95 0.00 0.27 0.00 0.65
Short term debt to equity ratio arrow
0.03 0.00 0.05 0.00 0.00
Current Ratio arrow
6.77 0.73 2.99 3.46 3.20
Quick Ratio arrow
6.44 0.73 2.32 3.38 2.94
Interest Coverage arrow
-1.58 -- 1.62 -- -9.32

Operating Efficiency Ratios

 Syndax Pharmaceuticals (SNDX) Medpace Holdings (MEDP) Ascendis Pharma A/S - ADR Exelixis (EXEL) Madrigal Pharmaceuticals (MDGL)
Debtors to sales (%) arrow
27.84 15.88 21.25 13.74 14.98
Asset Turnover arrow
0.33 0.89 0.44 0.83 0.91
Receivable days arrow
89.18 50.42 85.52 43.48 35.88
Inventory Days arrow
867.80 -- 1,056.70 96.17 354.23
Payable days arrow
739.04 6.26 331.01 147.97 300.79
Cash Conversion Cycle arrow
217.93 -- 811.21 -8.32 89.33
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...